Sg Americas Securities, LLC Mei Pharma, Inc. Transaction History

Sg Americas Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$0.54 - $2.74 $8,008 - $40,634	-14,830 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$2.33 - $3.37 $55,251 - $79,912	-23,713 Reduced 61.52%	14,830 $40,000
Q3 2021 Nov 01, 2021	BUY	$2.52 - $2.99 $97,128 - $115,243	38,543 New	38,543 $106,000
Q2 2021 Aug 12, 2021	SELL	$2.6 - $3.65 $51,344 - $72,080	-19,748 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$2.73 - $4.5 $17,671 - $29,128	6,473 Added 48.76%	19,748 $68,000
Q4 2020 Feb 04, 2021	BUY	$2.6 - $3.32 $34,515 - $44,073	13,275 New	13,275 $35,000
Q3 2020 Nov 09, 2020	SELL	$2.46 - $4.27 $141,819 - $246,165	-57,650 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$1.45 - $4.3 $29,872 - $88,588	20,602 Added 55.61%	57,650 $238,000
Q1 2020 Apr 30, 2020	BUY	$0.75 - $2.55 $27,786 - $94,472	37,048 New	37,048 $60,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $366M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.